- Home
- LGVN vs SMSI Comparison
LGVN vs SMSI Comparison
Compare LGVN & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- SMSI
- Stock Information
- Founded
- LGVN 2014
- SMSI 1982
- Country
- LGVN United States
- SMSI United States
- Employees
- LGVN N/A
- SMSI N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- SMSI Computer Software: Prepackaged Software
- Sector
- LGVN Health Care
- SMSI Technology
- Exchange
- LGVN Nasdaq
- SMSI Nasdaq
- Market Cap
- LGVN 16.4M
- SMSI 15.3M
- IPO Year
- LGVN 2021
- SMSI 1995
- Fundamental
- Price
- LGVN $0.77
- SMSI $0.77
- Analyst Decision
- LGVN Strong Buy
- SMSI Strong Buy
- Analyst Count
- LGVN 2
- SMSI 1
- Target Price
- LGVN $6.50
- SMSI $5.00
- AVG Volume (30 Days)
- LGVN 410.9K
- SMSI 130.5K
- Earning Date
- LGVN 11-11-2025
- SMSI 11-12-2025
- Dividend Yield
- LGVN N/A
- SMSI N/A
- EPS Growth
- LGVN N/A
- SMSI N/A
- EPS
- LGVN N/A
- SMSI N/A
- Revenue
- LGVN $2,073,000.00
- SMSI $18,658,000.00
- Revenue This Year
- LGVN N/A
- SMSI N/A
- Revenue Next Year
- LGVN N/A
- SMSI $59.48
- P/E Ratio
- LGVN N/A
- SMSI N/A
- Revenue Growth
- LGVN 68.67
- SMSI N/A
- 52 Week Low
- LGVN $0.63
- SMSI $0.60
- 52 Week High
- LGVN $2.48
- SMSI $1.95
- Technical
- Relative Strength Index (RSI)
- LGVN 38.17
- SMSI 57.55
- Support Level
- LGVN $0.74
- SMSI $0.71
- Resistance Level
- LGVN $0.85
- SMSI $0.76
- Average True Range (ATR)
- LGVN 0.05
- SMSI 0.04
- MACD
- LGVN 0.02
- SMSI 0.01
- Stochastic Oscillator
- LGVN 34.25
- SMSI 63.04
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.